B cell receptor light chain repertoires show signs of selection with differences between groups of healthy individuals and SLE patients

Molecular Immunology

Volumn 51, Issue 3-4, 2012, Pages 273-282

  Schoettler, Nathan ^a   Ni, Dongyao ^a   Weigert, Martin ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

B cell repertoire; Light chain; Receptor editing; SLE

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN;

ARTICLE; BLOOD; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIGHT CHAIN; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CASE-CONTROL STUDIES; GENE EXPRESSION; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MOLECULAR SEQUENCE DATA; PHENOTYPE; RECEPTORS, ANTIGEN, B-CELL;

EID: 84861222628     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.03.028     Document Type: Article

References (70)

1. Belessi C., Stamatopoulos K., Hadzidimitriou A., Hatzi K., Smilevska T., Stavroyianni N., Marantidou F., Paterakis G., Fassas A., Anagnostopoulos A., Laoutaris N. Analysis of expressed and non-expressed IGK locus rearrangements in chronic lymphocytic leukemia. Mol. Med. 2005, 11:52-58.
2. Bensimon C., Chastagner P., Zouali M. Human lupus anti-DNA autoantibodies undergo essentially primary V kappa gene rearrangements. EMBO J. 1994, 13:2951-2962.
3. Bentley D.L. Most kappa immunoglobulin mRNA in human lymphocytes is homologous to a small family of germ-line V genes. Nature 1984, 307:77-80.
4. Brauninger A., Goossens T., Rajewsky K., Kuppers R. Regulation of immunoglobulin light chain gene rearrangements during early B cell development in the human. Eur. J. Immunol. 2001, 31:3631-3637.
5. Casellas R., Jankovic M., Meyer G., Gazumyan A., Luo Y., Roeder R., Nussenzweig M. OcaB is required for normal transcription and V(D)J recombination of a subset of immunoglobulin kappa genes. Cell 2002, 110:575-585.
6. Chemin G., Tinguely A., Sirac C., Lechouane F., Duchez S., Cogne M., Delpy L. Multiple RNA surveillance mechanisms cooperate to reduce the amount of nonfunctional Ig kappa transcripts. J. Immunol. 2010, 184:5009-5017.
7. de Wildt R.M., Hoet R.M., van Venrooij W.J., Tomlinson I.M., Winter G. Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. J. Mol. Biol. 1999, 285:895-901.
8. de Wildt R.M., Steenbakkers P.G., Pennings A.H., van den Hoogen F.H., van Venrooij W.J., Hoet R.M. A new method for the analysis and production of monoclonal antibody fragments originating from single human B cells. J. Immunol. Methods 1997, 207:61-67.
9. Delpy L., Sirac C., Magnoux E., Duchez S., Cogne M. RNA surveillance down-regulates expression of nonfunctional kappa alleles and detects premature termination within the last kappa exon. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:7375-7380.
10. Dorner T., Farner N.L., Lipsky P.E. Ig lambda and heavy chain gene usage in early untreated systemic lupus erythematosus suggests intensive B cell stimulation. J. Immunol. 1999, 163:1027-1036.
11. Dorner T., Foster S.J., Farner N.L., Lipsky P.E. Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus. J. Clin. Invest. 1998, 102:688-694.
12. Dorner T., Hansen A., Jacobi A., Lipsky P.E. Immunglobulin repertoire analysis provides new insights into the immunopathogenesis of Sjogren's syndrome. Autoimmun. Rev. 2002, 1:119-124.
13. Dorner T., Kaschner S., Hansen A., Pruss A., Lipsky P.E. Perturbations in the impact of mutational activity on Vlambda genes in systemic lupus erythematosus. Arthritis Res. 2001, 3:368-374.
14. Doyle C.M., Han J., Weigert M.G., Prak E.T. Consequences of receptor editing at the lambda locus: multireactivity and light chain secretion. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:11264-11269.
15. Farner N.L., Dorner T., Lipsky P.E. Molecular mechanisms and selection influence the generation of the human V lambda J lambda repertoire. J. Immunol. 1999, 162:2137-2145.
16. Foster S.J., Brezinschek H.P., Brezinschek R.I., Lipsky P.E. Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells. J. Clin. Invest. 1997, 99:1614-1627.
17. Frippiat J.P., Williams S.C., Tomlinson I.M., Cook G.P., Cherif D., Le Paslier D., Collins J.E., Dunham I., Winter G., Lefranc M.P. Organization of the human immunoglobulin lambda light-chain locus on chromosome 22q11.2. Hum. Mol. Genet. 1995, 4:983-991.
18. Galin F.S., Maier C.C., Zhou S.R., Whitaker J.N., Blalock J.E. Murine V lambda x and V lambda x-containing antibodies bind human myelin basic protein. J. Clin. Invest. 1996, 97:486-492.
19. Gay D., Saunders T., Camper S., Weigert M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 1993, 177:999-1008.
20. Girschick H.J., Lipsky P.E. The kappa gene repertoire of human neonatal B cells. Mol. Immunol. 2002, 38:1113-1127.
21. Halverson R., Torres R.M., Pelanda R. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nat. Immunol. 2004, 5:645-650.
22. Heimbacher C., Hansen A., Pruss A., Jacobi A., Reiter K., Lipsky P.E., Dorner T. Immunoglobulin Vkappa light chain gene analysis in patients with Sjogren's syndrome. Arthritis Rheum. 2001, 44:626-637.
23. Hesse J.E., Lieber M.R., Mizuuchi K., Gellert M. V(D)J recombination: a functional definition of the joining signals. Genes Dev. 1989, 3:1053-1061.
24. Hieter P.A., Korsmeyer S.J., Waldmann T.A., Leder P. Human immunoglobulin kappa light-chain genes are deleted or rearranged in lambda-producing B cells. Nature 1981, 290:368-372.
25. Jacobi A.M., Hansen A., Kaufmann O., Pruss A., Burmester G.R., Lipsky P.E., Dorner T. Analysis of immunoglobulin light chain rearrangements in the salivary gland and blood of a patient with Sjogren's syndrome. Arthritis Res. 2002, 4:R4.
26. Kaschner S., Hansen A., Jacobi A., Reiter K., Monson N.L., Odendahl M., Burmester G.R., Lipsky P.E., Dorner T. Immunoglobulin Vlambda light chain gene usage in patients with Sjogren's syndrome. Arthritis Rheum. 2001, 44:2620-2632.
27. Kawasaki K., Minoshima S., Nakato E., Shibuya K., Shintani A., Asakawa S., Sasaki T., Klobeck H.G., Combriato G., Zachau H.G., Shimizu N. Evolutionary dynamics of the human immunoglobulin kappa locus and the germline repertoire of the Vkappa genes. Eur. J. Immunol. 2001, 31:1017-1028.
28. Kawasaki K., Minoshima S., Nakato E., Shibuya K., Shintani A., Schmeits J.L., Wang J., Shimizu N. One-megabase sequence analysis of the human immunoglobulin lambda gene locus. Genome Res. 1997, 7:250-261.
29. Kawasaki K., Minoshima S., Schooler K., Kudoh J., Asakawa S., de Jong P.J., Shimizu N. The organization of the human immunoglobulin lambda gene locus. Genome Res. 1995, 5:125-135.
30. Klein F., Feldhahn N., Mooster J.L., Sprangers M., Hofmann W.K., Wernet P., Wartenberg M., Muschen M. Tracing the pre-B to immature B cell transition in human leukemia cells reveals a coordinated sequence of primary and secondary IGK gene rearrangement, IGK deletion, and IGL gene rearrangement. J. Immunol. 2005, 174:367-375.
31. Klobeck H.G., Solomon A., Zachau H.G. Contribution of human V kappa II germ-line genes to light-chain diversity. Nature 1984, 309:73-76.
32. Klobeck H.G., Zachau H.G. The human CK gene segment and the kappa deleting element are closely linked. Nucleic Acids Res. 1986, 14:4591-4603.
33. Korsmeyer S.J., Hieter P.A., Ravetch J.V., Poplack D.G., Waldmann T.A., Leder P. Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:7096-7100.
34. Korsmeyer S.J., Hieter P.A., Sharrow S.O., Goldman C.K., Leder P., Waldmann T.A. Normal human B cells display ordered light chain gene rearrangements and deletions. J. Exp. Med. 1982, 156:975-985.
35. Lee J., Cho Y.J., Lipsky P.E. The V(lambda)-J(lambda) repertoire of patients with systemic lupus erythematosus manifests characteristics of the natural antibody repertoire. Arthritis Rheum. 2004, 50:2604-2614.
36. Lee J., Monson N.L., Lipsky P.E. The V lambda J lambda repertoire in human fetal spleen: evidence for positive selection and extensive receptor editing. J. Immunol. 2000, 165:6322-6333.
37. Li H., Jiang Y., Prak E.L., Radic M., Weigert M. Editors and editing of anti-DNA receptors. Immunity 2001, 15:947-957.
38. Li Y., Louzoun Y., Weigert M. Editing anti-DNA B cells by Vlambdax. J. Exp. Med. 2004, 199:337-346.
39. Louzoun Y., Friedman T., Luning Prak E., Litwin S., Weigert M. Analysis of B cell receptor production and rearrangement. Part I. Light chain rearrangement. Semin. Immunol. 2002, 14:169-190. discussion 221-222.
40. Matsuda F., Ishii K., Bourvagnet P., Kuma K., Hayashida H., Miyata T., Honjo T. The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J. Exp. Med. 1998, 188:2151-2162.
41. Mattson D.H., Roos R.P., Hopper J.E., Arnason B.G. Light chain composition of CSF oligoclonal IgG bands in multiple sclerosis and subacute sclerosing panencephalitis. J. Neuroimmunol. 1982, 3:63-76.
42. Meffre E., Chiorazzi M., Nussenzweig M.C. Circulating human B cells that express surrogate light chains display a unique antibody repertoire. J. Immunol. 2001, 167:2151-2156.
43. Meffre E., Davis E., Schiff C., Cunningham-Rundles C., Ivashkiv L.B., Staudt L.M., Young J.W., Nussenzweig M.C. Circulating human B cells that express surrogate light chains and edited receptors. Nat. Immunol. 2000, 1:207-213.
44. Meffre E., Schaefer A., Wardemann H., Wilson P., Davis E., Nussenzweig M.C. Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies. J. Exp. Med. 2004, 199:145-150.
45. Mehr R., Shannon M., Litwin S. Models for antigen receptor gene rearrangement. I. Biased receptor editing in B cells: implications for allelic exclusion. J. Immunol. 1999, 163:1793-1798.
46. Nadel B., Tang A., Escuro G., Lugo G., Feeney A.J. Sequence of the spacer in the recombination signal sequence affects V(D)J rearrangement frequency and correlates with nonrandom Vkappa usage in vivo. J. Exp. Med. 1998, 187:1495-1503.
47. Nemazee D., Weigert M. Revising B cell receptors. J. Exp. Med. 2000, 191:1813-1817.
48. Radic M.Z., Erikson J., Litwin S., Weigert M. B lymphocytes may escape tolerance by revising their antigen receptors. J. Exp. Med. 1993, 177:1165-1173.
49. Radoux V., Chen P.P., Sorge J.A., Carson D.A. A conserved human germline V kappa gene directly encodes rheumatoid factor light chains. J. Exp. Med. 1986, 164:2119-2124.
50. Richl P., Stern U., Lipsky P.E., Girschick H.J. The lambda gene immunoglobulin repertoire of human neonatal B cells. Mol. Immunol. 2008, 45:320-327.
51. Sanchez P., Marche P.N., Rueff-Juy D., Cazenave P.A. Mouse V lambda x gene sequence generates no junctional diversity and is conserved in mammalian species. J. Immunol. 1990, 144:2816-2820.
52. Schable K.F., Zachau H.G. The variable genes of the human immunoglobulin kappa locus. Biol. Chem. Hoppe Seyler 1993, 374:1001-1022.
53. Sekiguchi D.R., Yunk L., Gary D., Charan D., Srivastava B., Allman D., Weigert M.G., Prak E.T. Development and selection of edited B cells in B6.56R mice. J. Immunol. 2006, 176:6879-6887.
54. Shlomchik M., Nemazee D., van Snick J., Weigert M. Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). II. Comparison of hybridomas derived by lipopolysaccharide stimulation and secondary protein immunization. J. Exp. Med. 1987, 165:970-987.
55. Shlomchik M.J., Nemazee D.A., Sato V.L., Van Snick J., Carson D.A., Weigert M.G. Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). A structural explanation for the high frequency of IgM anti-IgG B cells. J. Exp. Med. 1986, 164:407-427.
56. Siminovitch K.A., Bakhshi A., Goldman P., Korsmeyer S.J. A uniform deleting element mediates the loss of kappa genes in human B cells. Nature 1985, 316:260-262.
57. Smith T.F., Waterman M.S. Identification of common molecular subsequences. J. Mol. Biol. 1981, 147:195-197.
58. Solomon A., Weiss D.T., Schell M., Ringelberg C., Ch'ang L.Y., Klebig M.L. Identification and characterization of a human Vlambda5 (T1) germline gene that encodes structurally unique lambda light chains. Mol. Immunol. 1997, 34:463-470.
59. Staudt L.M., Lenardo M.J. Immunoglobulin gene transcription. Annu. Rev. Immunol. 1991, 9:373-398.
60. Tiegs S.L., Russell D.M., Nemazee D. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 1993, 177:1009-1020.
61. van der Burg M., Tumkaya T., Boerma M., de Bruin-Versteeg S., Langerak A.W., van Dongen J.J. Ordered recombination of immunoglobulin light chain genes occurs at the IGK locus but seems less strict at the IGL locus. Blood 2001, 97:1001-1008.
62. Walker R.W., Keir G., Thompson E.J. Assessment of cerebrospinal fluid immunoglobulin patterns after isoelectric focusing. Use of kappa and lambda light chain immunoperoxidase staining. J. Neurol. Sci. 1983, 58:123-134.
63. Wardemann H., Hammersen J., Nussenzweig M.C. Human autoantibody silencing by immunoglobulin light chains. J. Exp. Med. 2004, 200:191-199.
64. Weigert M., Perry R., Kelley D., Hunkapiller T., Schilling J., Hood L. The joining of V and J gene segments creates antibody diversity. Nature 1980, 283:497-499.
65. Williams J.M., Gorevic P.D., Looney R.J., Abraham G.N. Isoelectric focusing characterization of IgM-VKiiib immunoglobulin light chains and their association with anti-IgG autoantibodies in essential mixed cryoglobulinaemia, Sjogren's syndrome and rheumatoid arthritis. Immunology 1987, 62:529-536.
66. Woo Y., Krueger W., Kaur A., Churchill G. Experimental design for three-color and four-color gene expression microarrays. Bioinformatics 2005, 21(Suppl. 1):i459-i467.
67. Wrammert J., Smith K., Miller J., Langley W.A., Kokko K., Larsen C., Zheng N.Y., Mays I., Garman L., Helms C., James J., Air G.M., Capra J.D., Ahmed R., Wilson P.C. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453:667-671.
68. Wu T.T., Kabat E.A. An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J. Exp. Med. 1970, 132:211-250.
69. Yurasov S., Tiller T., Tsuiji M., Velinzon K., Pascual V., Wardemann H., Nussenzweig M.C. Persistent expression of autoantibodies in SLE patients in remission. J. Exp. Med. 2006, 203:2255-2261.
70. Yurasov S., Wardemann H., Hammersen J., Tsuiji M., Meffre E., Pascual V., Nussenzweig M.C. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 2005, 201:703-711.